Table 2.

IGF 2 expression in LMP tumors and epithelial ovarian carcinoma (EOC)

Variable	LMP tumors (36)					EOC (79)					Totals (115)
	IGF2-Low N	(%)	IGF2-High N	(%)	p	IGF2-Low N	(%)	IGF2-High N	(%)	p	IGF2-Low N	(%)	IGF2-High N	(%)	p
Age					1.000					0.873					0.335
≤ 50 years	17	60.7	5	62.5		9	28.1	14	29.8		26	43.3	19	34.5
> 50 years	11	39.3	3	37.5		23	71.9	33	70.2		34	56.7	36	65.5
Race/Ethnicity					0.544					0.339					0.166
Non-Hispanic White	15	53.6	6	75.0		12	37.5	24	51.1		27	45.0	30	54.6
Hispanic	10	35.7	1	12.5		14	43.8	14	29.8		24	40.0	15	27.3
American Indian	1	3.6	0	0.0		1	3.1	0	0.0		6	10.0	10	18.2
Black	1	3.6	1	12.5		5	15.6	9	19.1		2	3.3	0	0.0
Asian	1	3.6	0	0.0		0	0.0	0	0.0		1	1.7	0	0.0
FIGO Stage					0.028					0.124					<0.001
I	27	96.4	5	62.5		12	37.5	12	25.5		39	65.0	17	30.9
II	0	0.0	2	25.0		4	12.5	3	6.4		4	6.7	5	9.1
III	1	3.6	1	12.5		15	46.9	23	48.9		16	26.7	24	43.6
IV	0	0.0	0	0.0		1	3.1	9	19.1		1	1.7	9	16.4
Histology					0.055					0.664					0.011
Serous	10	35.7	7	87.5		17	53.1	27	57.4		27	45.0	34	61.8
Mucinous	16	57.1	1	12.5		6	18.8	5	10.6		22	36.7	6	10.9
Endometrioid	0	0.0	0	0.0		3	9.4	3	6.4		3	5.0	3	5.5
Other	2	7.1	0	0.0		6	18.8	12	25.5		8	13.3	12	21.8
Tumor Grade					N/A					0.933					0.003
0	28	100.0	8	100.0		0	0.0	0	0.0		28	46.7	8	14.6
1	0	0.0	0	0.0		5	15.6	7	14.9		5	8.3	7	12.7
2	0	0.0	0	0.0		7	21.9	12	25.5		7	11 . 7	12	21.8
3	0	0.0	0	0.0		20	62.5	28	59.6		20	33.3	28	50.9
Total	28		8			32		47			60		55

IGF2-Low, H-score≤105; IGF2-High, H-score>105; N/A, not applicable